Aclaris Therapeutics, Inc. Liquidation Value
ACRS
Other
Cash & Equivalents
$19.96M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $19.96M
Total Obligations: -$30.76M
$-10.80M
Per share: $-0.09
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $19.96M
AR: $0
Total Obligations: -$30.76M
$-10.80M
Per share: $-0.09
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $19.96M
AR: $0
Inventory: $0
Total Obligations: -$30.76M
$-10.80M
Per share: $-0.09
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-10.80M | $-0.09 |
| Liquid Liquidation Value | $-10.80M | $-0.09 |
| Operating Liquidation Value | $-10.80M | $-0.09 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $19.96M |
| Accounts Receivable | $194,000 |
| Inventory | N/A |
| Current Liabilities | $28.64M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.12M |
| Finance Lease | N/A |
| Shares Outstanding | 120.5M |
Explore all 140 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $19.96M | N/A | N/A | $13.16M | $28.64M | N/A | $2.12M | N/A |
| 2025-09-30 | $25.26M | N/A | N/A | $9.19M | $25.63M | N/A | $2.24M | N/A |
| 2025-06-30 | $25.40M | $194,000 | N/A | $8.80M | $26.84M | N/A | $2.37M | N/A |
▼ Community Notes